Aram Mangasarian(@AramMangasarian) transformed NOXXON(@noxxon_pharma) into a lean, publicly quoted company focused on targeting the tumor microenvironment to improve the treatment solid tumors.

e-Meet Aram at #Sachs_ELSF

More info @ https://t.co/YXBF2fUYBz pic.twitter.com/rtScpQnKhx

— Sachs Associates (@SachsAssociates) January 11, 2021